AULT MILTON C III sold $3K of ALZN
AULT MILTON C III sold 2,000 shares of Alzamend Neuro, Inc. (ALZN) at $1.56 on 2026-08-26.
How this was made
The 30-second read
Why it matters
The director's complete exit may be noted by investors but is unlikely to move the stock materially.
Market read
Minor insider sell; low trading relevance.
What to watch
Potential upcoming dilution or strategic shift not disclosed.
Background
Form 4 filing discloses insider transactions to the market.
Ticker impact
Director Ault Milton C III sold 2,000 shares of Alzamend Neuro for $3,116, reducing his holding to zero.
No significant move; possible slight downward pressure.
The sale is small relative to market cap and represents a complete exit, but the amount is trivial and unlikely to affect valuation.
Market effects
None; isolated insider transaction.
None; company is US-listed biotech.
Low; no broader market effect.
Counterpoint
Even small insider sells can signal concerns; monitor upcoming news.
Key entities
- CompanyAlzamend Neuro, Inc.
US-listed biotech company (ticker ALZN).
- InsiderAult Milton C III
Director of Alzamend Neuro.
